Products
Milbemycin oxime is commercially available in combination with other antiparasitic agents in the form of tablets for animals. It has been approved in many countries since 2002.
Structure and properties
Milbemycin oxime (C32H44ClNO7, Mr = 590.1 g/mol) is a complex macrocyclic lactone.
Effects
Milbemycin oxime (ATCvet QP54AB51) has antiparasitic properties with a broad spectrum of activity.
Indications
In combination with lufenuron or praziquantel for treatment of worm infestation and prevention and control of flea infestation in dogs and cats.
